in this issue
World News and Views :: Projects
NPIL Pharma to Expand Capacity
October 17, 2007 | DR
NPIL Pharma, the custom manufacturing division of Nicholas Piramal India Ltd. (NPIL; Mumbai), says it will invest about $4 million in its early phase pharma development and scale-up (PDS) facility at Chennai, southern India. NPIL is India’s fourth-largest pharmaceutical company. NPIL says it will add eight new reactors with 12,000 liters of capacity to its Chennai cGMP plant by year-end. New facilities will be installed for manufacturing final active pharmaceutical ingredients (API), with a clean room for final API powder processing and packing. A new...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee